Crea il mio profilo
Accesso pubblico
Visualizza tutto13 articoli
5 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Brad H NelsonDirector, Deeley Research Centre, BC Cancer AgencyEmail verificata su bccancer.bc.ca
- Kelly McNagnyU of British ColumbiaEmail verificata su brc.ubc.ca
- Spencer D. Martin, MD PhDFaculty of Medicine, University of British columbiaEmail verificata su vch.ca
- Robert A. HoltHead of Sequencing, Michael Smith Genome Sciences Centre, BC Cancer Agency Distinguished ScientistEmail verificata su bcgsc.ca
- David KroegerAssociate Director BD, Zymeworks Inc.Email verificata su usask.ca
- Eric TranEarle A. Chiles Research Institute, Providence Cancer CenterEmail verificata su providence.org
- Kwame Twumasi-BoatengTelix PharmaceuticalsEmail verificata su telixpharma.com
- Ryan MorinProfessor, Simon Fraser University; Scientist at Genome Sciences Centre, BC Cancer AgencyEmail verificata su sfu.ca
- Randy D GascoyneProfessor of Pathology, University of British ColumbiaEmail verificata su bccancer.bc.ca
- Mauro CastellarinResearch Associate, University of Pennsylvania, Center for Cellular ImmunotherapiesEmail verificata su pennmedicine.upenn.edu
- Zabrina BrummeAssociate Professor, Faculty of Health Sciences, Simon Fraser UniversityEmail verificata su sfu.ca
- Michael R. HughesThe University of British ColumbiaEmail verificata su brc.ubc.ca
- Julia SalzmanAssociate Professor, Stanford UniversityEmail verificata su stanford.edu
- Marco MarraBC Cancer Agency; University of British Columbia, Genome Sciences CentreEmail verificata su bcgsc.ca
Segui
Julie S. Nielsen
Leader, Cell Manufacturing, BC Cancer's Immunotherapy Program
Email verificata su bccancer.bc.ca